Search Results
Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced preliminary net sales for the quarter and full year ended December 31, 2019, and preliminary full-year 2020 guidance for select financial metrics.
Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.
Baxter to Expand Advanced Surgery Portfolio with Acquisition of Seprafilm Adhesion Barrier
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. The agreement is the latest example of Baxter's continued focus on acquiring products and technologies that have a strong strategic fit with the company's leading portfolio across the hospital, including in the operating room.
Baxter Receives NYSE Notice Regarding Delayed Form 10-Q Filing
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019. The indicated annual dividend rate is $0.88 per share of common stock. About Baxter
Baxter and Ayogo Launch CKD&Me Patient Empowering Digital Education Tool at Kidney Week 2019
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Ayogo Health Inc., a behavioral science, digital health company, today announced the pilot of CKD&Me in several nephrology practices across the United States. Baxter and Ayogo partnered to build CKD&Me, a unique app for smartphones and tablets that tailors its educational content to chronic kidney disease (CKD) patients’ individual learning needs.
Baxter to Present at the Evercore ISI 2nd Annual HealthCONx Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 10:15 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 1, 2020. About Baxter
Baxter to Present at the 28th Annual Credit Suisse Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 11:30 a.m. Mountain Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through May 10, 2020.
Baxter Reports Preliminary Third Quarter 2019 Operating Results
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced certain preliminary operating results for the quarter ended September 30, 2019. Baxter further indicated that the Company is investigating misstatements in previously reported non-operating income. The internal investigation is described in further detail below.
Baxter Recognized as One of 2019 'Best Companies for Dads' by Working Mother
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that it has been named to Working Mother magazine’s 2019 'Best Companies for Dads' list for the first time. Baxter is focused on creating a positive and supportive work environment for all working parents and continues to expand on paternity and gender-neutral parental leave and flexible schedules.